AlphaBet: Combination of Radium-223 and [17 7Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol).
Front Med (Lausanne)
; 9: 1059122, 2022.
Article
in En
| MEDLINE
| ID: mdl-36465905
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Front Med (Lausanne)
Year:
2022
Document type:
Article
Affiliation country: